Αρχική World News FDA grants accelerated approval to vusolimogene oderparepvec-wtpg in combination with nivolumab for... World News FDA grants accelerated approval to vusolimogene oderparepvec-wtpg in combination with nivolumab for melanoma Από Ogkologos - 30 Σεπτεμβρίου, 2026 112 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the IGNYTE study Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Ahead of the Special European Council Meeting on 26-27 November, ESMO Calls on EU Governments to Continue Support for the Cancer Mission European Parliament backs key priorities advocated by ESMO for cancer research and innovation FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer MOST POPULAR Enhertu Marks First Targeted Therapy for HER2-Mutant Lung Cancer 13 Σεπτεμβρίου, 2022 Nivolumab Appears to Boost Cure Rate in Advanced Hodgkin Lymphoma 14 Νοεμβρίου, 2024 FDA Grants Accelerated Approval to Axicabtagene Ciloleucel for Relapsed or Refractory... 18 Μαρτίου, 2021 3rd Grader Writes Note for Teacher Battling Breast Cancer to Read... 24 Μαΐου, 2019 Φόρτωση περισσοτέρων HOT NEWS A Combination of Oral Mezigdomide Plus Dexamethasone Shows Promising Efficacy in... New Super-Microsurgical Procedure May Prevent Lymphedema in Breast Cancer Patients Sex, intimacy and cancer – That Cancer Conversation Reflections from our chief clinician: The essential role of our research...